NAV at lower edge of historical range with distribution cover at 56.4%

Against that shrinking capital base, the income statement swung back to profit: profit before tax of NZ$28.7m versus a NZ$16.8m loss (+270.8%), and NPAT of NZ$27.8m versus a NZ$18.1m loss (+254.1%), driven mostly by fair-value gains rather than dividend income. Investment income rose 10.5% to NZ$11.2m, and the portfolio's NAV total return of 8.2% beat the 5.1% reference-index return by 3.1pp. Gross borrowings stood at NZ$35.6m with cash of NZ$4.4m, leaving net debt of NZ$31.2m versus NZ$25.6m a year ago.

Net assets sit NZ$67.7m below the historical mean and NTA per share is 11.9% below HY23. This matters because the same distribution policy is now supported by a smaller pool of assets, which mechanically lifts the dividend yield on cost (release excerpts cite 11.3% versus 9.0% a year earlier) but also reduces the compounding base.

Distribution cover sits at 56.4%. Revenue return covered just over half of distributions paid in the period (NZ$19.9m), with the balance funded from capital. For an income-mandated trust this is a durability question rather than a near-term liquidity question, but a sustained pattern would erode NAV further on top of market drawdowns.

Portfolio performance beat the reference index by 3.1pp (8.2% versus 5.1%), wider than the 0.5pp outperformance in HY23 on the supplied baselines. Investment income growth of 10.5% is the cleaner read on underlying portfolio yield, separate from fair-value swings.

Annolyse's historical baseline shows HY23 contributed 27.2% of FY23 investment income, indicating a second-half-weighted income profile; a simple double of HY24 income annualises to roughly NZ$22.4m, but the historical shape implies a higher full-year figure. The larger expectations gap is on NAV: the current NZ$368.6m sits well below the NZ$436.3m four-period mean, and the supplied excerpts do not isolate how much of the shortfall reflects portfolio drawdown versus distributions exceeding earnings.

Investment total return of NZ$31.4m compares with investment income of NZ$11.2m, so roughly two-thirds of the reported result is fair-value driven and will move with Asian equity markets in the next half. The cleaner durability anchor is the 10.5% growth in investment income, which is within Annolyse's historical range (4-period mean NZ$18.7m) but well below that mean in absolute terms.

Two further quality flags. First, distribution cover of 56.4% means the period's income is not self-funding the dividend at the current payout rate. Second, gross borrowings of NZ$35.6m against a smaller equity base point to weakening leverage versus a year ago, with net debt of NZ$31.2m up from NZ$25.6m. Neither is alarming in isolation, but they compound the NAV-erosion read for an income-focused holder. ROE recovered to 7.6% from -4.4%, but that recovery is the same fair-value gain expressed against shareholders' funds, not an independent quality signal.

This briefing cannot assess the specific portfolio holdings, the gearing strategy, or management's internal view on distribution sustainability because none of those are disclosed in the supplied excerpts.